This brochure provides a comprehensive overview of our T2DM animal model portfolio and preclinical evaluation strategies. It includes:

• Diverse T2DM Model Portfolio: Covering commonly used induced and spontaneous models, including dietary, chemically induced, and genetically modified models, designed to reproduce different aspects of human T2DM pathology.
• Comprehensive Evaluation Criteria: A complete framework for metabolic assessment, including glucose homeostasis analysis, insulin sensitivity evaluation, lipid profiling, biochemical assays, and histopathological examination.
• Customized Study Design: Flexible experimental designs tailored to different therapeutic approaches, including anti-diabetic drug efficacy testing, mechanism-of-action studies, and biomarker discovery.
• Integrated Research Platforms: Combination of animal modeling with molecular biology, pathology, and metabolic analysis platforms to provide multidimensional insights into disease progression and treatment response.

Our validated T2DM models provide a reliable preclinical platform for evaluating small molecules, biologics, and emerging therapeutic strategies targeting metabolic disorders.

Download this brochure to explore detailed model information, experimental designs, and representative evaluation approaches. Contact Ace Therapeutics to discuss customized T2DM modeling solutions for your drug development program.

You might be interested in...